189 related articles for article (PubMed ID: 32550891)
1. Proinflammatory macrophage-derived microvesicles exhibit tumor tropism dependent on CCL2/CCR2 signaling axis and promote drug delivery
Guo L; Zhang Y; Wei R; Zhang X; Wang C; Feng M
Theranostics; 2020; 10(15):6581-6598. PubMed ID: 32550891
[No Abstract] [Full Text] [Related]
2. Macrophage-Derived Extracellular Vesicles as Drug Delivery Systems for Triple Negative Breast Cancer (TNBC) Therapy.
Haney MJ; Zhao Y; Jin YS; Li SM; Bago JR; Klyachko NL; Kabanov AV; Batrakova EV
J Neuroimmune Pharmacol; 2020 Sep; 15(3):487-500. PubMed ID: 31722094
[TBL] [Abstract][Full Text] [Related]
3. Targeting of tumour-infiltrating macrophages via CCL2/CCR2 signalling as a therapeutic strategy against hepatocellular carcinoma.
Li X; Yao W; Yuan Y; Chen P; Li B; Li J; Chu R; Song H; Xie D; Jiang X; Wang H
Gut; 2017 Jan; 66(1):157-167. PubMed ID: 26452628
[TBL] [Abstract][Full Text] [Related]
4. B7-H3 Suppresses Antitumor Immunity via the CCL2-CCR2-M2 Macrophage Axis and Contributes to Ovarian Cancer Progression.
Miyamoto T; Murakami R; Hamanishi J; Tanigaki K; Hosoe Y; Mise N; Takamatsu S; Mise Y; Ukita M; Taki M; Yamanoi K; Horikawa N; Abiko K; Yamaguchi K; Baba T; Matsumura N; Mandai M
Cancer Immunol Res; 2022 Jan; 10(1):56-69. PubMed ID: 34799346
[TBL] [Abstract][Full Text] [Related]
5. CCL2 shapes macrophage polarization by GM-CSF and M-CSF: identification of CCL2/CCR2-dependent gene expression profile.
Sierra-Filardi E; Nieto C; Domínguez-Soto A; Barroso R; Sánchez-Mateos P; Puig-Kroger A; López-Bravo M; Joven J; Ardavín C; Rodríguez-Fernández JL; Sánchez-Torres C; Mellado M; Corbí AL
J Immunol; 2014 Apr; 192(8):3858-67. PubMed ID: 24639350
[TBL] [Abstract][Full Text] [Related]
6. Estrogen receptor α promotes lung cancer cell invasion via increase of and cross-talk with infiltrated macrophages through the CCL2/CCR2/MMP9 and CXCL12/CXCR4 signaling pathways.
He M; Yu W; Chang C; Miyamoto H; Liu X; Jiang K; Yeh S
Mol Oncol; 2020 Aug; 14(8):1779-1799. PubMed ID: 32356397
[TBL] [Abstract][Full Text] [Related]
7. CCL2-CCR2 axis recruits tumor associated macrophages to induce immune evasion through PD-1 signaling in esophageal carcinogenesis.
Yang H; Zhang Q; Xu M; Wang L; Chen X; Feng Y; Li Y; Zhang X; Cui W; Jia X
Mol Cancer; 2020 Feb; 19(1):41. PubMed ID: 32103760
[TBL] [Abstract][Full Text] [Related]
8. Tunneling Nanotubular Expressways for Ultrafast and Accurate M1 Macrophage Delivery of Anticancer Drugs to Metastatic Ovarian Carcinoma.
Guo L; Zhang Y; Yang Z; Peng H; Wei R; Wang C; Feng M
ACS Nano; 2019 Feb; 13(2):1078-1096. PubMed ID: 30608136
[TBL] [Abstract][Full Text] [Related]
9. CCL2 overexpression is associated with paclitaxel resistance in ovarian cancer cells via autocrine signaling and macrophage recruitment.
Yang YI; Wang YY; Ahn JH; Kim BH; Choi JH
Biomed Pharmacother; 2022 Sep; 153():113474. PubMed ID: 36076499
[TBL] [Abstract][Full Text] [Related]
10. Dissecting the autocrine and paracrine roles of the CCR2-CCL2 axis in tumor survival and angiogenesis.
Izhak L; Wildbaum G; Jung S; Stein A; Shaked Y; Karin N
PLoS One; 2012; 7(1):e28305. PubMed ID: 22279523
[TBL] [Abstract][Full Text] [Related]
11. A MCP1 fusokine with CCR2-specific tumoricidal activity.
Rafei M; Deng J; Boivin MN; Williams P; Matulis SM; Yuan S; Birman E; Forner K; Yuan L; Castellino C; Boise LH; MacDonald TJ; Galipeau J
Mol Cancer; 2011 Sep; 10():121. PubMed ID: 21943176
[TBL] [Abstract][Full Text] [Related]
12. CCR2 signaling in breast carcinoma cells promotes tumor growth and invasion by promoting CCL2 and suppressing CD154 effects on the angiogenic and immune microenvironments.
Brummer G; Fang W; Smart C; Zinda B; Alissa N; Berkland C; Miller D; Cheng N
Oncogene; 2020 Mar; 39(11):2275-2289. PubMed ID: 31827233
[TBL] [Abstract][Full Text] [Related]
13. Defective expression of the monocyte chemotactic protein-1 receptor CCR2 in macrophages associated with human ovarian carcinoma.
Sica A; Saccani A; Bottazzi B; Bernasconi S; Allavena P; Gaetano B; Fei F; LaRosa G; Scotton C; Balkwill F; Mantovani A
J Immunol; 2000 Jan; 164(2):733-8. PubMed ID: 10623817
[TBL] [Abstract][Full Text] [Related]
14. Blocking the CCL2-CCR2 Axis Using CCL2-Neutralizing Antibody Is an Effective Therapy for Hepatocellular Cancer in a Mouse Model.
Teng KY; Han J; Zhang X; Hsu SH; He S; Wani NA; Barajas JM; Snyder LA; Frankel WL; Caligiuri MA; Jacob ST; Yu J; Ghoshal K
Mol Cancer Ther; 2017 Feb; 16(2):312-322. PubMed ID: 27980102
[TBL] [Abstract][Full Text] [Related]
15. Human umbilical cord mesenchymal stem cells delivering sTRAIL home to lung cancer mediated by MCP-1/CCR2 axis and exhibit antitumor effects.
Yan C; Song X; Yu W; Wei F; Li H; Lv M; Zhang X; Ren X
Tumour Biol; 2016 Jun; 37(6):8425-35. PubMed ID: 26733169
[TBL] [Abstract][Full Text] [Related]
16. CCR2 Chemokine Receptors Enhance Growth and Cell-Cycle Progression of Breast Cancer Cells through SRC and PKC Activation.
Yao M; Fang W; Smart C; Hu Q; Huang S; Alvarez N; Fields P; Cheng N
Mol Cancer Res; 2019 Feb; 17(2):604-617. PubMed ID: 30446625
[TBL] [Abstract][Full Text] [Related]
17. The chemokine (CCL2-CCR2) signaling axis mediates perineural invasion.
He S; He S; Chen CH; Deborde S; Bakst RL; Chernichenko N; McNamara WF; Lee SY; Barajas F; Yu Z; Al-Ahmadie HA; Wong RJ
Mol Cancer Res; 2015 Feb; 13(2):380-90. PubMed ID: 25312961
[TBL] [Abstract][Full Text] [Related]
18. Targeting the CCL2/CCR2 Axis in Cancer Immunotherapy: One Stone, Three Birds?
Fei L; Ren X; Yu H; Zhan Y
Front Immunol; 2021; 12():771210. PubMed ID: 34804061
[TBL] [Abstract][Full Text] [Related]
19. MCP-1/CCL2 Mediated by Autocrine Loop of PDGF-BB Promotes Invasion of Lung Cancer Cell by Recruitment of Macrophages Via CCL2-CCR2 Axis.
Ding M; He SJ; Yang J
J Interferon Cytokine Res; 2019 Apr; 39(4):224-232. PubMed ID: 30730243
[TBL] [Abstract][Full Text] [Related]
20. Combining magnetic nanoparticles with cell derived microvesicles for drug loading and targeting.
Silva AK; Luciani N; Gazeau F; Aubertin K; Bonneau S; Chauvierre C; Letourneur D; Wilhelm C
Nanomedicine; 2015 Apr; 11(3):645-55. PubMed ID: 25596340
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
